SEC Info uses JavaScript! To view pages properly, enable JavaScript in your browser.
On: Wednesday, 5/12/21, at 4:46pm ET · For: 3/31/21 · Accession #: 1828182-21-17 · File #: 1-40028
Text Wildcards: ? (any letter/digit) , * (many) . Search Logic: for Documents: & (and ) , | (or) ; for Text: | (anywhere ) , "(&)" (near) . Details...
Quarterly Report — Form 10-Q Filing Table of Contents
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 754K
2: EX-10.1 Material Contract HTML 68K
3: EX-10.2 Material Contract HTML 67K
4: EX-31.1 Certification -- §302 - SOA'02 HTML 27K
5: EX-31.2 Certification -- §302 - SOA'02 HTML 27K
6: EX-32.1 Certification -- §906 - SOA'02 HTML 25K
7: EX-32.2 Certification -- §906 - SOA'02 HTML 25K
14: R1 Cover Page HTML 78K
15: R2 Condensed Consolidated Balance Sheets HTML 153K
16: R3 Consolidated Balance Sheets (Parenthetical) HTML 32K
17: R4 Condensed Consolidated Statements of Operations HTML 111K
18: R5 Condensed Consolidated Statements of Changes in HTML 73K
Stockholders' / Members? Equity
19: R6 Condensed Consolidated Statements of Cash Flows HTML 126K
20: R7 Nature of Operations HTML 34K
21: R8 Significant Accounting Policies HTML 55K
22: R9 The COVID-19 Pandemic HTML 33K
23: R10 Variable Interest Entities HTML 45K
24: R11 Revenue Recognition HTML 96K
25: R12 Property and Equipment HTML 36K
26: R13 Intangible Assets HTML 46K
27: R14 Accounts Payable and Accrued Expenses HTML 34K
28: R15 Long-Term Debt HTML 44K
29: R16 Fair Value Measurements HTML 82K
30: R17 Shareholders' Equity HTML 38K
31: R18 Noncontrolling Interest HTML 31K
32: R19 Equity-Based Compensation HTML 36K
33: R20 Loss Per Share HTML 35K
34: R21 Transaction-related Expenses HTML 26K
35: R22 Commitment and Contingencies HTML 40K
36: R23 Income Taxes HTML 34K
37: R24 Segment Reporting HTML 56K
38: R25 Concentrations HTML 27K
39: R26 Related Party Transactions HTML 30K
40: R27 Significant Accounting Policies (Policies) HTML 74K
41: R28 Significant Accounting Policies (Tables) HTML 40K
42: R29 Variable Interest Entities (Tables) HTML 47K
43: R30 Revenue Recognition (Tables) HTML 93K
44: R31 Property and Equipment (Tables) HTML 35K
45: R32 Intangible Assets (Tables) HTML 47K
46: R33 Accounts Payable and Accrued Expenses (Tables) HTML 34K
47: R34 Long-Term Debt (Tables) HTML 46K
48: R35 Fair Value Measurements (Tables) HTML 86K
49: R36 Noncontrolling Interest (Tables) HTML 30K
50: R37 Loss Per Share (Tables) HTML 32K
51: R38 Commitment and Contingencies (Tables) HTML 29K
52: R39 Segment Reporting (Tables) HTML 50K
53: R40 Nature of Operations (Details) HTML 54K
54: R41 Significant Accounting Policies - Narrative HTML 47K
(Details)
55: R42 Significant Accounting Policies - Cash, Cash HTML 33K
Equivalents and Restricted Cash (Details)
56: R43 Variable Interest Entities - Narrative (Details) HTML 38K
57: R44 Variable Interest Entities - Schedule of Variable HTML 86K
Interest Entities (Details)
58: R45 Revenue Recognition - Narrative (Details) HTML 26K
59: R46 Revenue Recognition - Disaggregation of Revenue HTML 40K
(Details)
60: R47 Revenue Recognition - Schedule of Related Balance HTML 54K
Sheets Account (Details)
61: R48 Revenue Recognition - Contract Assets (Details) HTML 28K
62: R49 Revenue Recognition - Contract Liabilities HTML 32K
(Details)
63: R50 Revenue Recognition - Deferred Revenue (Details) HTML 30K
64: R51 Revenue Recognition - Shared Savings Payable HTML 29K
(Details)
65: R52 Property and Equipment - Property and Equipment, HTML 43K
net (Details)
66: R53 Property and Equipment - Narrative (Details) HTML 28K
67: R54 Intangible Assets - Schedule of Intangible Assets HTML 44K
(Details)
68: R55 Intangible Assets - Narrative (Details) HTML 30K
69: R56 Intangible Assets - Schedule of Expected HTML 39K
Amortization Expense (Details)
70: R57 Accounts Payable and Accrued Expenses (Details) HTML 39K
71: R58 Long-Term Debt - Schedule of Long-Term Debt HTML 48K
(Details)
72: R59 Long-Term Debt - Narrative (Details) HTML 44K
73: R60 Long-Term Debt - Future Principal Maturities of HTML 37K
Long-Term Debt (Details)
74: R61 Fair Value Measurements - Schedule of Assets and HTML 46K
Liabilities Measured at Fair Value on a Recurring
Basis (Details)
75: R62 Fair Value Measurements - Changes in Contingent HTML 40K
Consideration and Customer Equity Appreciation
Rights (Details)
76: R63 Fair Value Measurements - Schedule of Valuation HTML 55K
Techniques and Significant Unobservable Inputs
(Details)
77: R64 Shareholders' Equity (Details) HTML 48K
78: R65 Noncontrolling Interest (Details) HTML 39K
79: R66 Equity-Based Compensation (Details) HTML 94K
80: R67 Loss Per Share - Schedule of Earnings (Loss) Per HTML 70K
Share (Details)
81: R68 Loss Per Share - Narrative (Details) HTML 34K
82: R69 Transaction-related Expenses - Narrative (Details) HTML 31K
83: R70 Commitment and Contingencies - Narrative (Details) HTML 65K
84: R71 Commitment and Contingencies - Summary of SEU HTML 35K
Activity (Details)
85: R72 Income Taxes (Details) HTML 49K
86: R73 Segment Reporting - Narrative (Details) HTML 25K
87: R74 Segment Reporting - Schedule of Operating Segment HTML 69K
Results (Details)
88: R75 Concentrations (Details) HTML 43K
89: R76 Related Party Transactions (Details) HTML 38K
90: R9999 Uncategorized Items - sgfy-20210331.htm HTML 80K
92: XML IDEA XML File -- Filing Summary XML 165K
13: XML XBRL Instance -- sgfy-20210331_htm XML 1.68M
91: EXCEL IDEA Workbook of Financial Reports XLSX 112K
9: EX-101.CAL XBRL Calculations -- sgfy-20210331_cal XML 236K
10: EX-101.DEF XBRL Definitions -- sgfy-20210331_def XML 727K
11: EX-101.LAB XBRL Labels -- sgfy-20210331_lab XML 1.59M
12: EX-101.PRE XBRL Presentations -- sgfy-20210331_pre XML 1.03M
8: EX-101.SCH XBRL Schema -- sgfy-20210331 XSD 183K
93: JSON XBRL Instance as JSON Data -- MetaLinks 402± 573K
94: ZIP XBRL Zipped Folder -- 0001828182-21-000017-xbrl Zip 318K
‘EX-32.2’ — Certification — §906 – SOA’02
This Exhibit is an HTML Document rendered as filed. [ Alternative Formats ]
<!
C:
C:
Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Signify Health, Inc. (the “Company” ), for the quarterly period ended March 31, 2021 , as filed with the Securities and Exchange Commission on the date hereof (the “Report” ),
each of the undersigned officers of the Company certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company .
/s/ Steve Senneff Steven Senneff President, Chief Financial and Administrative Officer
Dates Referenced Herein and Documents Incorporated by Reference
This ‘10-Q’ Filing Date Other Filings Filed on: 5/12/21 For Period end: 3/31/21 4 List all Filings
↑ Top Filing Submission 0001828182-21-000017 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)
Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.About — Privacy — Redactions — Help —
Mon., Apr. 29, 5:04:12.1pm ET